Breast-Conserving Therapy is Associated with Improved Survival Without an Increased Risk of Locoregional Recurrence Compared with Mastectomy in Both Clinically Node-Positive and Node-Negative Breast Cancer Patients.

Vasilyeva, Elizaveta; Hamm, Jeremy; Nichol, Alan; Isaac, Kathryn V; Bazzarelli, Amy; Brown, Carl; Lohrisch, Caroline; McKevitt, Elaine

Vasilyeva, Elizaveta; Hamm, Jeremy; Nichol, Alan; Isaac, Kathryn V; Bazzarelli, Amy; Brown, Carl; Lohrisch, Caroline; McKevitt, Elaine.

Afiliación

Vasilyeva E; Department of Surgery, University of British Columbia, Vancouver, BC, Canada. elizaveta.vasilyeva@vch.ca.
Hamm J; BC Cancer, Vancouver, BC, Canada. elizaveta.vasilyeva@vch.ca.
Nichol A; BC Cancer, Vancouver, BC, Canada.
Isaac KV; Department of Surgery, University of British Columbia, Vancouver, BC, Canada.
Bazzarelli A; BC Cancer, Vancouver, BC, Canada.
Brown C; Department of Surgery, University of British Columbia, Vancouver, BC, Canada.
Lohrisch C; Department of Surgery, University of British Columbia, Vancouver, BC, Canada.
McKevitt E; BC Cancer, Vancouver, BC, Canada.

Ann Surg Oncol ; 30(11): 6413-6424, 2023 Oct.

Article en En | MEDLINE | ID: mdl-37358683

Asunto(s)

Neoplasias de la Mama; Mastectomía; Humanos; Femenino; Neoplasias de la Mama/patología; Mastectomía Segmentaria; Estudios Retrospectivos; Estudios Prospectivos; Estudios de Seguimiento; Recurrencia Local de Neoplasia/patología; Estadificación de Neoplasias

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Mastectomía Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Ann Surg Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google